1470P Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence

• DOI: 10.1016/j.annonc.2021.08.797
• Publication Date: 2021-09-21T14:51:00Z
• Authors: T.R. Heumann; M. Baretti; E. Sugar; J. Durhman; S. Liden; T. Miles; T.Y. Lopez-Vidal; J. Leatherman; A. Sharma; N. Ahuja; C.D. Weekes; P.J. O'Dwyer; D.K. Monga; K.A. Reiss Binder; N. Azad
• Keywords: Azacitidine